Merck (MRK) Equity Income (2009 - 2014)

Merck has disclosed Equity Income across 5 years of filings, most recently posting $16.0 million for Q4 2014.

• In Q4 2014, Equity Income fell 69.81% year-over-year to $16.0 million; the TTM figure through Dec 2014 stood at $256.0 million (down 36.63% YoY), while the FY2014 annual figure was $257.0 million, down 36.39% from the prior year.
• Equity Income retreated to $16.0 million in Q4 2014, from $24.0 million in the prior quarter.
• Over the last five years, Equity Income for MRK reached as high as $256.0 million in Q4 2011 and fell as low as $16.0 million in Q4 2014.
• The 4-year median for Equity Income is $120.0 million (2013), against an average of $122.8 million.
• The widest YoY moves for Equity Income: up 20.91% in 2013, down 77.16% in 2013.
• A 4-year view of Equity Income shows it stood at $256.0 million in 2011, then decreased by 9.38% to $232.0 million in 2012, then plunged by 77.16% to $53.0 million in 2013, then plunged by 69.81% to $16.0 million in 2014.
• According to Business Quant data, Equity Income over the past three periods registered $16.0 million, $24.0 million, and $92.0 million for Q4 2014, Q3 2014, and Q2 2014 respectively.